Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Growth Rate is Predicted for the Oral Biologics & Biosimilars Market for 2024-2033?
In recent times, there has been a significant expansion in the market size of oral biologics & biosimilars. Projections indicate that its growth will increase from $6471.49 billion in 2023 up to $7788.01 billion in 2024, at a compound annual growth rate (CAGR) of 20.3%. Factors contributing to this growth during the historical period include greater collaborations and partnerships between market participants to gain deeper understanding, an escalated need for immunology, and a rising demand driven by cost-efficient manufacturing processes. Moreover, contributing factors also include an ageing population, government initiatives, and the capability to demand high prices.
In the coming years, the market size for oral biologics & biosimilars is projected to witness substantial growth, escalating to a value of $16634.59 billion in 2028 at a compound annual growth rate (CAGR) of 20.9%. This projected growth in the given period is due to robust R&D activities relating to the development of oral biologics, preferences for pills over injections, adoption of poor lifestyle routines, advancements in technology, the user-friendly nature of oral biologics, increased access to healthcare, biologics reimbursement, the growth of biosimilars, and the increasing instances of chronic illnesses. Notable trends forecasted for the period includes capital investment in the oral biologics market for high profit margin potential, a shift towards using biologics due to a rise in innovation in this field, and the creation of drugs based on microneedle injectors to increase bioavailability and mitigate the side effects associated with the subcutaneous administration route.
Claim Your Free Sample of the Global Oral Biologics & Biosimilars Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=6830&type=smp
What Drivers Are Enhancing the oral biologics & biosimilars Market’s Growth?
The escalating incidence of chronic illnesses such as arthritis, asthma, and cancer is anticipated to drive the expansion of the oral biologics and biosimilar market. The rise in chronic diseases can be attributed to extended working periods, insufficient physical movement, and poor dietary and drinking choices, leading to an increased use of biologics as a treatment method. Biologics boost the immune system’s assault on cancer cells, helping natural bodily defenses to eliminate the cells responsible for the disease. As cited in a report by a US-based intergovernmental organization from United Nations, by 2030, chronic diseases are expected to be the cause of 70% of all global deaths. It is predicted that chronic diseases will result in approximately 60% of all worldwide fatalities. Hence, the increasing rates of chronic diseases are fueling the expansion of the biologics and biosimilar market.
What Segments Are Central to the Oral Biologics & Biosimilars Market?
1) By Therapy: Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors, Immunostimulants, GPCR Modulators, Other Therapies
2) By Disease: Diabetes, Arthritis and Crohn’s Disease, Cancer, Infectious Disease, Other Autoimmune Disease, Other Diseases
3) By Molecule Type: Vaccines, Proteins and Peptides, Monoclonal Antibodies, Other Molecule Types
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
What Emerging Trends Are Influencing Oral Biologics & Biosimilars Industry Dynamics?
A significant trend emerging in the field of oral biologics and biosimilars is the development of new insulin biosimilar products. Recognizing this trend, the primary players in the market are making investments to produce biosimilar versions of insulin, in a bid to increase their market share. To illustrate, Biocon, a biopharmaceutical company from India, introduced an interchangeable biosimilar insulin in November 2021. These products are aimed at managing high blood sugar levels in children with type 1 diabetes and adults with type 2 diabetes and are distributed in both vial and prefilled pen packages. These biosimilars can be interchanged with the reference brand, Lantus (insulin glargine), even at the pharmacy level. The development of insulin biosimilars, therefore, represents a key area of investment for companies in the oral biologics and biosimilar market looking to capitalize on this trend.
Order Now for Fast Delivery of Your Oral Biologics & Biosimilars Market Report!
Which Geographic Locations Are Critical to the Growth of the Oral Biologics & Biosimilars Market?
North America was the largest region in the oral biologics and biosimilar drugs market in 2023. The Middle East is expected to be the fastest-growing region in the forecast period. The regions covered in the oral biologics & biosimilars market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Oral Biologics & Biosimilars Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the oral biologics & biosimilars market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Oral Biologics & Biosimilars Market Include
1. Oral Biologics & Biosimilars Market Executive Summary
2. Oral Biologics & Biosimilars Market Segments
3. Oral Biologics & Biosimilars Market Size And Template Market Growth Rate
4. Key Oral Biologics & Biosimilars Market Trends
5. Major Oral Biologics & Biosimilars Market Drivers
……
25. Key Mergers And Acquisitions In The Oral Biologics & Biosimilars Market
26. Top Oral Biologics & Biosimilars Companies
27. Oral Biologics & Biosimilars Market Opportunities And Strategies
28. Oral Biologics & Biosimilars Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Pharmacy Inventory Management Software Solutions and Cabinets Global Market Report 2024
Pharmaceutical Drugs And Biologics Logistics Global Market Report 2024
Active Pharmaceutical Ingredients Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
